Takeda ordered to pay patient $6.5m over Actos drug cancer risk

Japanese pharmaceutical giant Takeda has been ordered to pay $6.5m in damages to a Californian man after jurors found the company failed to provide the claimant and his doctors with adequate warnings about the bladder cancer risk from its Actos diabe…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news